Drug Interactions
Comprehensive guide to drug-drug interactions, pharmacokinetic interactions, and interaction management.
Browse the pages below for detailed information.
diazepam — GABAA receptor α1 subunit Interaction
Drug-target interaction between diazepam and GABAA receptor α1 subunit. Synthetic organic pharmacological agent targeting this protein.
diazepam — GABAA receptor α2 subunit Interaction
Drug-target interaction between diazepam and GABAA receptor α2 subunit. Synthetic organic pharmacological agent targeting this protein.
diazepam — GABAA receptor α3 subunit Interaction
Drug-target interaction between diazepam and GABAA receptor α3 subunit. Synthetic organic pharmacological agent targeting this protein.
diclofenac — COX-1 Interaction
Drug-target interaction between diclofenac and COX-1. Synthetic organic pharmacological agent targeting this protein.
diclofenac — COX-2 Interaction
Drug-target interaction between diclofenac and COX-2. Synthetic organic pharmacological agent targeting this protein.
dicumarol — vitamin K epoxide reductase complex subunit 1 Interaction
Drug-target interaction between dicumarol and vitamin K epoxide reductase complex subunit 1. Synthetic organic pharmacological agent targeting this protein.
dicyclomine — M1 receptor Interaction
Drug-target interaction between dicyclomine and M1 receptor. Synthetic organic pharmacological agent targeting this protein.
dicyclomine — M3 receptor Interaction
Drug-target interaction between dicyclomine and M3 receptor. Synthetic organic pharmacological agent targeting this protein.
diethylstilbestrol — Estrogen receptor-α Interaction
Drug-target interaction between diethylstilbestrol and Estrogen receptor-α. Synthetic organic pharmacological agent targeting this protein.
difelikefalin — κ receptor Interaction
Drug-target interaction between difelikefalin and κ receptor. Peptide pharmacological agent targeting this protein.
diflorasone diacetate — Glucocorticoid receptor Interaction
Drug-target interaction between diflorasone diacetate and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
difluprednate — Glucocorticoid receptor Interaction
Drug-target interaction between difluprednate and Glucocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
digitoxin — sodium/potassium-transporting ATPase subunit α-1 Interaction
Drug-target interaction between digitoxin and sodium/potassium-transporting ATPase subunit α-1. Synthetic organic pharmacological agent targeting this protein.
digoxin — sodium/potassium-transporting ATPase subunit α-1 Interaction
Drug-target interaction between digoxin and sodium/potassium-transporting ATPase subunit α-1. Natural product pharmacological agent targeting this protein.
dihydroergotamine — 5-HT1D receptor Interaction
Drug-target interaction between dihydroergotamine and 5-HT1D receptor. Synthetic organic pharmacological agent targeting this protein.
diltiazem — Cav1.1 Interaction
Drug-target interaction between diltiazem and Cav1.1. Synthetic organic pharmacological agent targeting this protein.
diphenhydramine — H1 receptor Interaction
Drug-target interaction between diphenhydramine and H1 receptor. Synthetic organic pharmacological agent targeting this protein.
dipyridamole — Equilibrative nucleoside transporter 1 Interaction
Drug-target interaction between dipyridamole and Equilibrative nucleoside transporter 1. Synthetic organic pharmacological agent targeting this protein.
disitamab vedotin — erb-b2 receptor tyrosine kinase 2 Interaction
Drug-target interaction between disitamab vedotin and erb-b2 receptor tyrosine kinase 2. Antibody pharmacological agent targeting this protein.
divozilimab — CD20 (membrane-spanning 4-domains, subfamily A, member 1) Interaction
Drug-target interaction between divozilimab and CD20 (membrane-spanning 4-domains, subfamily A, member 1). Antibody pharmacological agent targeting this protein.
dobutamine — β1-adrenoceptor Interaction
Drug-target interaction between dobutamine and β1-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
docetaxel — tubulin beta class I Interaction
Drug-target interaction between docetaxel and tubulin beta class I. Synthetic organic pharmacological agent targeting this protein.
dofetilide — Kv11.1 Interaction
Drug-target interaction between dofetilide and Kv11.1. Synthetic organic pharmacological agent targeting this protein.
domperidone — D2 receptor Interaction
Drug-target interaction between domperidone and D2 receptor. Synthetic organic pharmacological agent targeting this protein.
domperidone — D3 receptor Interaction
Drug-target interaction between domperidone and D3 receptor. Synthetic organic pharmacological agent targeting this protein.
donepezil — acetylcholinesterase (Yt blood group) Interaction
Drug-target interaction between donepezil and acetylcholinesterase (Yt blood group). Synthetic organic pharmacological agent targeting this protein.
dopamine — D1 receptor Interaction
Drug-target interaction between dopamine and D1 receptor. Metabolite pharmacological agent targeting this protein.
dopamine — D2 receptor Interaction
Drug-target interaction between dopamine and D2 receptor. Metabolite pharmacological agent targeting this protein.
dopamine — D3 receptor Interaction
Drug-target interaction between dopamine and D3 receptor. Metabolite pharmacological agent targeting this protein.
dopamine — D4 receptor Interaction
Drug-target interaction between dopamine and D4 receptor. Metabolite pharmacological agent targeting this protein.
dopamine — D5 receptor Interaction
Drug-target interaction between dopamine and D5 receptor. Metabolite pharmacological agent targeting this protein.
dostarlimab — programmed cell death 1 (CD279) Interaction
Drug-target interaction between dostarlimab and programmed cell death 1 (CD279). Antibody pharmacological agent targeting this protein.
dosulepin — NET Interaction
Drug-target interaction between dosulepin and NET. Synthetic organic pharmacological agent targeting this protein.
dosulepin — SERT Interaction
Drug-target interaction between dosulepin and SERT. Synthetic organic pharmacological agent targeting this protein.
dotinurad — Urate anion exchanger 1 Interaction
Drug-target interaction between dotinurad and Urate anion exchanger 1. Synthetic organic pharmacological agent targeting this protein.
doxazosin — α1A-adrenoceptor Interaction
Drug-target interaction between doxazosin and α1A-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
doxazosin — α1B-adrenoceptor Interaction
Drug-target interaction between doxazosin and α1B-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
doxazosin — α1D-adrenoceptor Interaction
Drug-target interaction between doxazosin and α1D-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
doxepin — NET Interaction
Drug-target interaction between doxepin and NET. Synthetic organic pharmacological agent targeting this protein.
doxepin — SERT Interaction
Drug-target interaction between doxepin and SERT. Synthetic organic pharmacological agent targeting this protein.
doxycycline — MMP7 Interaction
Drug-target interaction between doxycycline and MMP7. Synthetic organic pharmacological agent targeting this protein.
dromostanolone propionate — Androgen receptor Interaction
Drug-target interaction between dromostanolone propionate and Androgen receptor. Synthetic organic pharmacological agent targeting this protein.
drospirenone — Mineralocorticoid receptor Interaction
Drug-target interaction between drospirenone and Mineralocorticoid receptor. Synthetic organic pharmacological agent targeting this protein.
drotrecogin alfa — coagulation factor V Interaction
Drug-target interaction between drotrecogin alfa and coagulation factor V. Peptide pharmacological agent targeting this protein.
drotrecogin alfa — coagulation factor VIII Interaction
Drug-target interaction between drotrecogin alfa and coagulation factor VIII. Peptide pharmacological agent targeting this protein.
Drug-Drug Interactions Overview
Drug-drug interactions occur when one drug affects the pharmacokinetics or pharmacodynamics of another drug, leading to altered therapeutic effects or toxicity.
duloxetine — NET Interaction
Drug-target interaction between duloxetine and NET. Synthetic organic pharmacological agent targeting this protein.
duloxetine — SERT Interaction
Drug-target interaction between duloxetine and SERT. Synthetic organic pharmacological agent targeting this protein.
dupilumab — Interleukin-4 receptor subunit α Interaction
Drug-target interaction between dupilumab and Interleukin-4 receptor subunit α. Antibody pharmacological agent targeting this protein.
duvelisib — phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta Interaction
Drug-target interaction between duvelisib and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta. Synthetic organic pharmacological agent targeting this protein.
duvelisib — phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma Interaction
Drug-target interaction between duvelisib and phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma. Synthetic organic pharmacological agent targeting this protein.
dydrogesterone — Progesterone receptor Interaction
Drug-target interaction between dydrogesterone and Progesterone receptor. Synthetic organic pharmacological agent targeting this protein.
ebronucimab — proprotein convertase subtilisin/kexin type 9 Interaction
Drug-target interaction between ebronucimab and proprotein convertase subtilisin/kexin type 9. Antibody pharmacological agent targeting this protein.
edoxaban — coagulation factor X Interaction
Drug-target interaction between edoxaban and coagulation factor X. Synthetic organic pharmacological agent targeting this protein.
efalizumab — integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) Interaction
Drug-target interaction between efalizumab and integrin, alpha L subunit (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide). Antibody pharmacological agent targeting t
efgartigimod alfa — Fc fragment of IgG receptor and transporter Interaction
Drug-target interaction between efgartigimod alfa and Fc fragment of IgG receptor and transporter. Antibody pharmacological agent targeting this protein.
eflornithine — Ornithine decarboxylase Interaction
Drug-target interaction between eflornithine and Ornithine decarboxylase. Synthetic organic pharmacological agent targeting this protein.
elagolix — GnRH1 receptor Interaction
Drug-target interaction between elagolix and GnRH1 receptor. Synthetic organic pharmacological agent targeting this protein.
eletriptan — 5-HT1B receptor Interaction
Drug-target interaction between eletriptan and 5-HT1B receptor. Synthetic organic pharmacological agent targeting this protein.
eletriptan — 5-HT1D receptor Interaction
Drug-target interaction between eletriptan and 5-HT1D receptor. Synthetic organic pharmacological agent targeting this protein.